Capital Fund Management (CFM)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.4M Buy
140,109
+119,169
+569% +$40.6M 0.42% 86
2025
Q4
$8.33M Buy
+20,940
New +$9.27M 0.08% 922
2024
Q3
Sell
-41,821
Closed -$10.2M 1963
2024
Q2
$10.2M Buy
41,821
+11,454
+38% +$1.81M 0.12% 665
2024
Q1
$4.54M Buy
+30,367
New +$5.07M 0.06% 1093
2020
Q2
Sell
-8,332
Closed -$907K 1009
2020
Q1
$907K Buy
+8,332
New +$962K 0.03% 826
2019
Q4
Hold
0
1805
2018
Q4
Sell
-5,127
Closed -$449K 1819
2018
Q3
$449K Buy
+5,127
New +$516K 0.01% 1635
2018
Q2
Hold
0
1959
2018
Q1
Sell
-1,674
Closed -$216K 1813
2017
Q4
$213K Buy
+1,674
New +$210K ﹤0.01% 1729
2017
Q3
Hold
0
1501
2017
Q2
Hold
0
1450
2017
Q1
Hold
0
1441
2016
Q4
Hold
0
1621
2016
Q3
Sell
-49,622
Closed -$2.75M 1547
2016
Q2
$2.75M Sell
49,622
-9,828
-17% -$619K 0.05% 633
2016
Q1
$3.73M Buy
+59,450
New +$3.95M 0.06% 524
2015
Q4
Sell
-32,956
Closed -$2.65M 1525
2015
Q3
$2.65M Buy
32,956
+22,749
+223% +$2.53M 0.06% 539
2015
Q2
$1.22M Sell
10,207
-5,964
-37% -$713K 0.03% 773
2015
Q1
$1.69M Buy
+16,171
New +$1.64M 0.04% 621
2014
Q2
Sell
-16,411
Closed -$1.1M 1647
2014
Q1
$1.1M Buy
16,411
+1,825
+13% +$141K 0.03% 917
2013
Q4
$938K Buy
+14,586
New +$870K 0.02% 1004
2013
Q3
Hold
0
1550

Other funds holding ALNY